ICD-10 Codes Used in Pediatric Exposure to Intimate Partner Violence

Mohammed Sayeem1, May Shum2, Caitlin Ryus3

  • 1Yale New Haven Children's Hospital (M Sayeem, E Powers, and G Tiyyagura), New Haven, Conn.

Academic Pediatrics
|February 6, 2026
PubMed

Insights

Pediatric visits for intimate partner violence (IPV) exposure often use non-specific ICD-10 codes. Documentation varied between the pediatric emergency department (PED) and child advocacy center (CAC), limiting systematic identification of IPV.

Area of Science:

  • Pediatric healthcare
  • Public health
  • Medical coding

Background:

  • Intimate partner violence (IPV) significantly impacts child well-being.
  • Accurate identification of IPV exposure in pediatric settings is crucial for intervention.
  • Current diagnostic coding practices may not effectively capture all IPV-related pediatric encounters.

Purpose of the Study:

  • To identify common International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes used for pediatric visits related to caregiver IPV.
  • To compare the use of IPV-related diagnostic codes between pediatric emergency department (PED) and child advocacy center (CAC) evaluations.
  • To assess the specificity and effectiveness of ICD-10 codes for identifying IPV in pediatric healthcare settings.

Main Methods:

  • Secondary analysis of pediatric encounters for IPV-related care from July 2019 to June 2022.
  • Inclusion of visits to the PED or CAC following a child protective service referral.
  • Descriptive summarization of ICD-10-CM codes and examination of code usage based on evaluation site.

Main Results:

  • 174 distinct ICD-10 codes were identified across 92 pediatric encounters.
  • 85% of encounters were associated with IPV-related diagnostic codes, suspected abuse, or social concerns (e.g., Z63, T74, T76, Z60).
  • Child advocacy center (CAC) encounters were significantly more likely to have IPV-related codes than pediatric emergency department (PED) evaluations (98% vs. 66%, p <0.01).

Conclusions:

  • ICD-10 code groups Z63, T74, T76, and Z60 are frequently used but lack specificity for IPV.
  • Variability in code usage between CAC and PED settings may indicate provider uncertainty or safety concerns.
  • ICD-10 codes alone are insufficient for robustly identifying pediatric IPV exposure due to limited specificity and documentation inconsistencies.
Abstract

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.7K
Nursing Code of Ethics01:29

Nursing Code of Ethics

The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
317
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
237